Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2471.71 | 2641 / 2642 | 81% | 1.68 | 570 / 705 |
pancreas | 99% | 1395.80 | 326 / 328 | 79% | 1.58 | 141 / 178 |
esophagus | 100% | 3295.11 | 1445 / 1445 | 74% | 1.32 | 136 / 183 |
thymus | 100% | 2486.58 | 653 / 653 | 71% | 1.37 | 432 / 605 |
uterus | 100% | 2336.98 | 170 / 170 | 69% | 1.37 | 317 / 459 |
lung | 100% | 2455.19 | 577 / 578 | 68% | 1.50 | 786 / 1155 |
bladder | 100% | 3514.10 | 21 / 21 | 66% | 1.38 | 334 / 504 |
breast | 100% | 3007.39 | 459 / 459 | 64% | 1.18 | 711 / 1118 |
prostate | 100% | 3256.82 | 245 / 245 | 57% | 0.89 | 288 / 502 |
kidney | 100% | 2735.53 | 89 / 89 | 55% | 1.18 | 495 / 901 |
ovary | 100% | 1905.93 | 180 / 180 | 53% | 0.93 | 229 / 430 |
intestine | 100% | 3466.39 | 966 / 966 | 50% | 0.82 | 262 / 527 |
adrenal gland | 100% | 2727.55 | 258 / 258 | 47% | 0.74 | 107 / 230 |
skin | 100% | 3025.25 | 1809 / 1809 | 45% | 0.74 | 213 / 472 |
stomach | 100% | 2256.21 | 359 / 359 | 40% | 0.59 | 113 / 286 |
liver | 100% | 1219.66 | 225 / 226 | 9% | 0.17 | 36 / 406 |
adipose | 100% | 2921.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3797.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3558.89 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2686.84 | 920 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 1737.82 | 846 / 861 | 0% | 0 | 0 / 0 |
muscle | 94% | 934.68 | 757 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 1.93 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 64% | 1.11 | 29 / 45 |
eye | 0% | 0 | 0 / 0 | 24% | 0.36 | 19 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0010324 | Biological process | membrane invagination |
GO_0016236 | Biological process | macroautophagy |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0097320 | Biological process | plasma membrane tubulation |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0051258 | Biological process | protein polymerization |
GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
GO_0032511 | Biological process | late endosome to vacuole transport via multivesicular body sorting pathway |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0050877 | Biological process | nervous system process |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0030117 | Cellular component | membrane coat |
GO_0005886 | Cellular component | plasma membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005771 | Cellular component | multivesicular body |
GO_0005737 | Cellular component | cytoplasm |
GO_1904930 | Cellular component | amphisome membrane |
GO_0005768 | Cellular component | endosome |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008289 | Molecular function | lipid binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP4A |
Protein name | Charged multivesicular body protein 4A Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1) |
Synonyms | SHAX2 HSPC134 C14orf123 CDA04 |
Description | FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. When overexpressed, membrane-assembled circular arrays of CHMP4A filaments can promote or stabilize negative curvature and outward budding. Via its interaction with PDCD6IP involved in HIV-1 p6- and p9-dependent virus release. CHMP4A/B/C are required for the exosomal release of SDCBP, CD63 and syndecan . . |
Accessions | E9PQI5 ENST00000530996.5 ENST00000645308.4 [Q9BY43-1] ENST00000533011.5 H0YIN6 ENST00000347519.12 [Q9BY43-1] H0YI89 E9PQ80 Q9BY43 ENST00000533523.6 ENST00000534106.2 |